期刊文献+

重新认识肾动脉狭窄的发生与发展, 规范肾动脉狭窄的介入治疗 被引量:15

Re-recognize the significance and development of renal artery stenosis and standardize the interventional therapy
下载PDF
导出
摘要 回顾肾动脉狭窄(RAS)的流行病学及临床特点,对肾动脉腔内血管成形和支架术(PTRA/S)的适应证、禁忌证、并发症、操作技术等作一评述。虽然国内外已将(PTRA/S)作为RAS的首选治疗,但国内相关临床研究有待加强。 The epidemiology and clinical characteristics of renal arterial stenosis(RAS)were reviewed; and the indication, contraindication, complication and interventional techniques of percutaneous renal angioplasty and stenting(PTRA/S)had been commented. It is believed that there are a lot of study and work to be done in China for standardizing the interventional therapy, in spite of PTRA/S already been the first choice of RAS therapy in the world.(J Intervent Radiol, 2007, 16: 433-435)
作者 邹英华
出处 《介入放射学杂志》 CSCD 2007年第7期433-435,共3页 Journal of Interventional Radiology
关键词 肾动脉狭窄 肾动脉腔内血管成形和支架术 Renal artery stenosis Percutaneous renal angioplasty and stenting
  • 相关文献

参考文献7

  • 1Hansen KJ,Edwards MS,Craven TE,et al.Prevalence of renovascular disease in the elderly:a population-based study[J].J Vase Surg,2002,36:443-451.
  • 2Safian RD,Textor SC.Renal-artery stenosis[J].N Engl J Med,2001,344:431 -442.
  • 3王芳,王梅,王海燕.动脉粥样硬化患者肾动脉狭窄患病率的调查[J].中华肾脏病杂志,2005,21(3):139-142. 被引量:66
  • 4Caps MT,Perissinotto C,Zierler RE,et al.Prospective study of atherosclerotic disease progression in the renal artery[J].Circulation,1998,98:2866-2872.
  • 5Mailloux LU,Napolitano B,Bellucci AG,et al.Renal vascular disease causing end-stage renal disease,incidence,clinical correlates,and outcomes:a 20-year clinical experience[J].Am J Kidney Dis,1994,24:622-629.
  • 6Dean RH,Kieffer RW,Smith BM,et al.Renovascular hypertension:anatomic and renal function changes during drug therapy[J].Arch Surg,1981,116:1408-1415.
  • 7Kennedy DJ,Burket MW,Khuder SA,et al.Quality of life improves after renal artery stenting[J].Biologic Res Nursing,2006,8:129-137.

二级参考文献16

  • 1Mailloux LU, Napolitano B, Bellucci AG, et al. Renal vascular disease causing end-stage renal disease, incidence,clinical correlates, and outcomes:a 20-year clinical experience.Am J Kidney Dis, 1994,24:622-629.
  • 2Conlon PJ, Athirakul K, Kovalik E, et al. Survival in renal vascular disease. J Am Soc Nephrol, 1998,9:252-256.
  • 3Harding MB, Smith LR, Himmelstein SI, et al. Renal artery stenosis: prevalence and associated risk factors in patients undergoing routine cardiac catheterization. J Am Soc Nephrol,1992,2:1608-1616.
  • 4Vetrovec GW, Landwehr DM, Edwards VL. Incidence of renal artery stenosis in hypertensive patients undergoing coronary angiography.J Intervent Cardio, 1989,2:69-76.
  • 5Setsuko K, Naoki N, Takashi U. Prevalence of renal artery stenosis in autopsy patients with stroke. Stroke, 2000,31:61.
  • 6Choudhri AH, Cleland JG, Rowlands PC, et al. Unsuspected renal artery stenosis in peripheral vascular disease. Br J Med,1990,301:1197-1198.
  • 7Salmon P, Brown MA. Renal artery stenosis and peripheral vascular disease: implication for ACE inhibitor therapy.Lancet, 1990,336:321.
  • 8Crook E. The role of hypertension, obesity, and diabetes in causing renal vascular disease. Am J Med, 1999, 317:183-188.
  • 9Graham IM, Daly LE, Refsum HM, et al. Plasma homocysteine as a risk factor for vascular disease. The European Concerted Action Project.JAMA,1997, 277:1775-1781.
  • 10Christen WG, Ridker PM. Blood levels of homocysteine and atherosclerotic vascular disease. Curr Atheroscler Rep, 2000,2:194-1991.

共引文献65

同被引文献128

引证文献15

二级引证文献58

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部